Commonwealth Financial Services LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 19,708 shares of the exchange traded fund’s stock, valued at approximately $2,403,000.
Other institutional investors have also recently made changes to their positions in the company. Legacy Wealth Managment LLC ID bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $32,000. Ballast Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $36,000. Creative Financial Designs Inc. ADV bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $39,000. Barnes Dennig Private Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $48,000. Finally, Navalign LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $48,000.
SPDR S&P Biotech ETF Stock Up 0.8%
Shares of NYSEARCA:XBI opened at $132.78 on Friday. The firm’s 50 day moving average price is $129.72 and its 200-day moving average price is $125.00. SPDR S&P Biotech ETF has a twelve month low of $78.00 and a twelve month high of $139.19. The stock has a market capitalization of $8.47 billion, a PE ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Featured Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
